Acura Pharmaceuticals Revenue 2010-2021 | ACUR

Acura Pharmaceuticals revenue from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Acura Pharmaceuticals Annual Revenue
(Millions of US $)
2021 $2
2020 $4
2019 $3
2018 $0
2017 $3
2016 $4
2015 $9
2014 $1
2013 $0
2012 $0
2011 $20
2010 $3
2009 $4
Acura Pharmaceuticals Quarterly Revenue
(Millions of US $)
2021-12-31 $0
2021-09-30 $0
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $0
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $3
2016-12-31 $4
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $3
2015-09-30 $0
2015-06-30 $0
2015-03-31 $5
2014-12-31 $1
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $0
2011-09-30
2011-06-30 $20
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $1
2010-03-31 $2
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.303B 6.73
Dr Reddy's Laboratories (RDY) India $11.772B 21.36
BridgeBio Pharma (BBIO) United States $8.662B 0.00
Bausch Health Cos (BHC) Canada $2.365B 1.70
Supernus Pharmaceuticals (SUPN) United States $1.879B 15.26
Amphastar Pharmaceuticals (AMPH) United States $1.006B 6.75
Taysha Gene Therapies (TSHA) United States $0.588B 0.00
Personalis (PSNL) United States $0.494B 0.00
Assembly Biosciences (ASMB) United States $0.137B 0.00
Sol-Gel Technologies (SLGL) Israel $0.035B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00